Telcare, a US-based provider of monitors that let people know their blood-sugar levels, has raised $25.5m in its series B round from a consortium including chip maker Qualcomm’s $100m Life corporate venturing fund.
Venture capital firm Sequoia Capital led the B round, which followed a $4.5m A round from a consortium also including Qualcomm at the end of last year. Telcare was founded in 2008.
Jack Young, director of Qualcomm Ventures and head if the Kife Fund, said: “Telcare’s solution leverages the broad coverage of mobile networks and the convenience of cellular technology to empower individuals to better manage their conditions through professional supervision and/or family members’ support.”
The two investors had also been part of a syndicate backing remote patient monitoring company AirStrip Technologies in February. Qualcomm Life Fund was set up in December from the existing allocation for Qualcomm Ventures, with an aim to help roll out Qualcomm’s 2net Platform and is solely focused on investing in digital/mobile health start-ups.
Aside from Telcare and Airstrip Qualcomm had invested in four other wireless health companies – Sotera Wireless, AliveCor, Cambridge Temperature Concepts and WorkSmart Labs (now called Noom). Young is a board observer at Airstrip, AliveCor and Telcare.